The Role of Lymph Node Density in Predicting Survival Post-Cystectomy in Patients with Bladder Cancer; A Single-Center Retrospective Analysis
Archives of Men's Health,
Vol. 8 No. 1 (2024),
31 July 2024
,
Page e3
https://doi.org/10.22037/mhj.v8i1.44360
Abstract
Background: Lymph Node involvement in patients with bladder cancer directly affects their prognosis after cystectomy. With the advent of various extensions for lymphadenectomy during radical cystectomy, Lymph Node Density (LND) has been introduced as a stable measure to quantify the extent of LN involvement. This study evaluates the prognostic value of LND on the survival of these patients in our center. Methods: Our historical cohort reviewed the clinical records of 165 patients who underwent cystectomy at Modarres Hospital in Tehran, Iran during 2012-2018. The presence of positive LNs, the total number of positive LN, and LN density were evaluated for their effect on Overall survival (OS) and recurrence-free survival (RFS) at 3- and 5-years post-surgery. In addition, we assessed the impact of age, gender, type of diversion, P stage, lymphovascular invasion (LVI), location of involved LNs, ureteral involvement, positive surgical margin, and the presence of carcinoma in situ on patients’ survival. Results: According to ROC curve analysis, an LND cut-off point of 10.82 was calculated to predict patients’ survival (AUC:0.70, 95%CI: 0.496-0.691). An LND >10.82 significantly increased the risk of cancer-related death. Among all study variables, LND had the most prominent effect on OS (HR:2.49, 95% CI:1.3-4.4, P=0.002). For 3- and 5-year RFS, LVI had the highest impact (HR: 2.63, 95% CI: 1.3-5.1, P=0.005 and HR: 1.96, 95% CI: 1.2-3.0, P=0.002, respectively) Conclusion: Our analysis indicates that an LND >10.82 has the highest predictive potential for OS among the pathological features of patients undergoing cystectomy.
- Bladder cancer
- Lymph-node density
- Radical cystectomy
- Overall survival
How to Cite
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
Ku JH, Kang M, Kim HS, Jeong CW, Kwak C, Kim HH. Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis. BMC Cancer. 2015;15:447.
Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003;170(1):35-41.
Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol. 2003;169(3):943-5.
Lee D, Yoo S, You D, Hong B, Cho YM, Hong JH, et al. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy. Urol Oncol. 2017;35(4):151.e1-.e7.
Jensen JB, Ulhøi BP, Jensen KM. Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery. BJU Int. 2012;109(3):388-93.
Wiesner C, Salzer A, Thomas C, Gellermann-Schultes C, Gillitzer R, Hampel C, et al. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int. 2009;104(3):331-5.
Horn T, Schmid SC, Seitz AK, Grab J, Wolf P, Haller B, et al. Clinical prognosticators of survival in patients with urothelial carcinoma of the bladder and lymph node metastases after cystectomy with curative intent. World J Urol. 2015;33(6):813-9.
Kassouf W, Svatek RS, Shariat SF, Novara G, Lerner SP, Fradet Y, et al. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol Oncol. 2013;31(4):480-6.
Simone G, Papalia R, Ferriero M, Guaglianone S, Naselli A, Collura D, et al. Development and external validation of lymph node density cut-off points in prospective series of radical cystectomy and pelvic lymph node dissection. Int J Urol. 2012;19(12):1068-74.
May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, et al. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol. 2011;59(5):712-8.
Jaganmurugan R, Arora A, Chandankhede U, Prakash G, Bakshi G, Joshi A, et al. Prognostic Significance of Lymph Node Density in Pathological Node Positive Urothelial Carcinoma of the Bladder -Upfront Surgery and Post Neoadjuvant Chemotherapy Cohorts. Clin Genitourin Cancer. 2024;22(2):385-93.
Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K, et al. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study. Int J Urol. 2009;16(3):274-8; discussion 8.
Stephenson AJ, Gong MC, Campbell SC, Fergany AF, Hansel DE. Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer. Urology. 2010;75(2):382-6.
Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol. 2005;23(10):2358-65.
Guzzo TJ, Resnick MJ, Canter DJ, Balandra A, Bergey MR, Magerfleisch L, et al. Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy. Can J Urol. 2010;17(6):5465-71.
Kwon T, Jeong IG, You D, Hong B, Hong JH, Ahn H, et al. Long-term oncologic outcomes after radical cystectomy for bladder cancer at a single institution. J Korean Med Sci. 2014;29(5):669-75.
Morgan TM, Barocas DA, Penson DF, Chang SS, Ni S, Clark PE, et al. Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. Urology. 2012;80(3):632-40.
Mmeje CO, Nunez-Nateras R, Nielsen ME, Pruthi RS, Smith A, Wallen EM, et al. Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years. Urol Oncol. 2013;31(8):1621-7.
Kassouf W, Agarwal PK, Herr HW, Munsell MF, Spiess PE, Brown GA, et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol. 2008;26(1):121-6.
Raza SJ, Miller C, May A, Davaro F, Siddiqui SA, Hamilton Z. Lymph node density for stratification of survival outcomes with node positive upper tract urothelial carcinoma. Can J Urol. 2019;26(4):9852-8.
- Abstract Viewed: 308 times
- pdf Downloaded: 234 times